Pharmacokinetic (PK) Evaluation of Nalmefene Formulations

Clinical trial NCT07543276 · COMPLETED

Trial details

NCT number: NCT07543276
Sponsor: Knoa Pharma LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Overdose

Start date: 2026-02-06
Primary completion: 2026-04-03
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.